Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.6%

7 terminated/withdrawn out of 270 trials

Success Rate

89.6%

+3.0% vs industry average

Late-Stage Pipeline

9%

24 trials in Phase 3/4

Results Transparency

5%

3 of 60 completed trials have results

Key Signals

72 recruiting3 with results4 withdrawn

Enrollment Performance

Analytics

N/A
74(46.3%)
Phase 2
36(22.5%)
Phase 1
19(11.9%)
Phase 4
17(10.6%)
Phase 3
7(4.4%)
Early Phase 1
7(4.4%)
160Total
N/A(74)
Phase 2(36)
Phase 1(19)
Phase 4(17)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (270)

Showing 20 of 270 trials
NCT07443462Not ApplicableNot Yet Recruiting

Evaluation of the Effects of Pulsed Electromagnetic Field on Inflammatory Knee Osteoarthritis

Role: collaborator

NCT07796386Not Yet Recruiting

Plasma Neprilysin for Predicting Sepsis Within 48 Hours in ICU Patients With Infection or Suspected Infection

Role: lead

NCT07791667Phase 1Not Yet Recruiting

The Therapeutic Potential of Mesenchymal Stem Cell-derived Exosomes in Peritoneal Dysfunction

Role: lead

NCT07380113Phase 4Recruiting

Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP

Role: lead

NCT07754188Recruiting

Early Complications After Flow Diverter Versus Stent-Assisted Coiling for Unruptured Wide-Neck Intracranial Bifurcation Aneurysms

Role: collaborator

NCT07696481Early Phase 1Not Yet Recruiting

Clinical Study on the Safety and Efficacy of PID23 Injection in Patients With Relapsed/Refractory Acute Leukemia

Role: lead

NCT05270200Phase 1Recruiting

Single Arm Study of Post-transplant Azacitidine and Chidamide for Prevention of Acute Myelogenous Leukemia Relapse

Role: lead

NCT07686575Recruiting

Objective Response Rate of Ivonescimab With Chemotherapy in Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinoma

Role: lead

NCT06858059Not ApplicableCompleted

A Randomized Controlled Trial of the Efficacy of the Lighthouse Parenting Programme in Addressing Parenting Difficulties in China

Role: lead

NCT07674004Not ApplicableRecruiting

Surface-Modified Flow Diverter for Intracranial Aneurysms: Assessment of Ischemic and Clinical Outcomes

Role: collaborator

NCT07645846Phase 2Not Yet Recruiting

Neoadjuvant Docetaxel, Cisplatin, and Dual Immunotherapy for Sinonasal Carcinoma

Role: collaborator

NCT07620626Recruiting

Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment

Role: collaborator

NCT07604688Recruiting

Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China

Role: collaborator

NCT07454421Phase 1Enrolling By Invitation

Racecadotril for Organ Injury in Sepsis Patients

Role: lead

NCT07176182Phase 2Recruiting

Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression

Role: collaborator

NCT07524699Not ApplicableNot Yet Recruiting

A Study About Remote and Local Liver Surgery

Role: collaborator

NCT07581769Active Not Recruiting

Radiomics Subtyping to Guide Surgery vs. Maintenance Therapy After HCC Downstaging

Role: collaborator

NCT05194189Phase 2Completed

Clinical Efficacy of Megadose Vitamin C in Sepsis

Role: lead

NCT07584330Not Yet Recruiting

AI-Driven Metabolic Cohort in Overweight/Obese Chinese Adults

Role: lead

NCT05738083Recruiting

Multi-Center Registry Cohort Study on Prognostic Factors and Prediction Model Construction in Aneurysmal SAH

Role: collaborator